Mesa Laboratories, Inc.
MLAB
$103.99
$4.204.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -324.46% | -148.89% | 1.18% | 101.33% | -12,131.33% |
| Total Depreciation and Amortization | 36.38% | -9.41% | 11.03% | -13.19% | -30.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -76.52% | 520.37% | -7.09% | -99.24% | 53,305.92% |
| Change in Net Operating Assets | 171.85% | 159.31% | -1,677.22% | -103.95% | 8,411.65% |
| Cash from Operations | -31.31% | 249.82% | -49.48% | -19.02% | 11.69% |
| Capital Expenditure | 6.89% | 54.53% | -100.67% | -66.54% | 52.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 101.21% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -23.86% | 54.53% | -100.67% | -309.15% | 100.53% |
| Total Debt Issued | -- | -- | -100.00% | -- | -100.00% |
| Total Debt Repaid | -84.02% | -31.07% | 90.78% | -601.63% | -27.78% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.12% | -0.35% | -0.35% | 0.12% | -0.23% |
| Other Financing Activities | 4,190.00% | 106.51% | 69.99% | -414.07% | 31.38% |
| Cash from Financing | -52.81% | -23.08% | 5.48% | 29.57% | -121.25% |
| Foreign Exchange rate Adjustments | 319.51% | -141.33% | 666.86% | 54.66% | -136.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -154.92% | 260.07% | -1,702.71% | 2,680.00% | 99.86% |